Bradley A. Bugdanowitz

Brad Bugdanowitz is a retired partner of Goodwin, an international law firm. He previously served as counsel to the firm's business law department. From 2008 to 2020, Mr. Bugdanowitz was a partner in the firm’s business law department specializing in merger and acquisition transactions and securities offerings, also serving as Chairman of the San Francisco office from 2012 to 2017.

Mr. Bugdanowitz’s experience includes representing:

• Teva Pharmaceuticals Industries, Ltd. in its acquisition of Auspex Pharmaceuticals
• Viveve Medical in its underwritten public offering, ATM facility and corporate governance 
• Onyx Pharmaceuticals in its sale to Amgen
• Roxro Pharma in its sale to Luitpold Pharmaceuticals.
• Codenomicon Oy in its sale to Synopsys International Limited
• Royalty Pharma in its acquisition of royalties resulting from commercialization of the drug ibrutinib from Quest Diagnostics, and related collaboration with Aisling Capital and Clarus Ventures
• ECG Management Consultants, Inc. in its recapitalization by Gryphon Investors
• Anthera Pharmaceuticals, Inc. in its collaboration with Zenyaku Kogyo Co Ltd., preferred stock and convertible note financings, initial and follow-on public common stock offerings, SEC reporting and governance matters
• Growth Street Partners in its investments in Pear Deck, Visual Lease, Hotel Effectiveness and ChildCare CRM
• Trigemina Holdings, Inc. in its reinversion transaction from Chile to the United States and related financing transactions
• Sprout Health Group in its growth equity investment by Housatonic Partners
• NIKE in its $2 billion aggregate bond offerings, strategic partnership with Dyecoo Textile Systems, B.V., SEC reporting and governance matters
• Passport Capital in its investment in NEOS GeoSolutions
• JMI Equity in its investments in SiriusDecisions, BigMachines and Paradigm, Ltd.
• Altos Therapeutics, Aspire Medical, BioClin Therapeutics, Trigemina Holdings, Radiant Medical, Resonance Medical, Wireless Glue Networks in Preferred equity financing transactions
• Management group in its management led leveraged buyout of Entek Holdings LLC and subsequent representation of ENTEK in its recapitalization, financing and partnership transactions
• Outward Bound USA, Inc., Pacific Crest Outward Bound School and the Northwest Outward Bound School in various matters on a pro bono basis.